Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.

Saphner T, Troxel AB, Tormey DC, Neuberg D, Robert NJ, Pandya KJ, Edmonson JH, Rosenbluth RJ, Abeloff MD. Phase II study of goserelin for patients with postmenopausal metastatic breast cancer. J Clin Oncol. 1993 Aug; 11(8):1529-35.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.